Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Persistence Pays Off: 2021 Midyear Advocacy Update

Elizabeth (Blair) Solow, MD  |  May 21, 2021

Sequester is an automatic reduction in federal spending.4 Due to large spending packages by the government for COVID-19, additional sequester cuts—separate from the PFS—will begin Dec. 31 if not addressed. Expiration of a moratorium on a sequester that has been on pause through 2020 and 2021 will result in 2% cuts to reimbursement, and a new sequester, called PAYGO, will add across-the-board 4% cuts.

How you can help: Watch for calls to action on the ACR’s Legislative Action Center in support of suspending or repealing cuts.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Workforce
Workforce initiatives continue to be at the forefront of the ACR’s advocacy efforts. Nationally, pediatric rheumatology fellowship programs fill around 50% of their slots. Meanwhile, adult rheumatology fellowship slots must turn away applicants. The cap on Medicare support for graduate medical education has been in place for more than two decades via the Balanced Budget Act of 1997.

The Resident Physician Shortage Reduction Act (S. 834/H.R. 2256) was re-introduced. This bill adds 14,000 Medicare-funded graduate medical education slots over seven years.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Pediatric Subspecialty Loan Repayment Program (PSLRP) would address the pediatric workforce shortage by providing funds for loan forgiveness when certain metrics are met. Although the PSLRP was authorized by the CARES Act in 2020, it has not yet been funded. The ACR is advocating for an initial $50 million appropriation.

At the state level, we are also making progress on our workforce initiatives. The ACR’s model, cognitive care loan forgiveness bill was re-introduced in the Georgia House of Representatives this year. In Washington, pediatric rheumatology loan forgiveness was amended into the state budget. This would be the first state to allow pediatric rheumatologists to apply to state loan forgiveness programs. We are working with our partners to ensure this provision stays in the budget that is sent to the governor.

How you can help: Visit the Legislative Action Center to find a pre-populated letter to legislators you can send showing your support for these workforce actions.

Arthritis Research
The U.S. Department of Defense allocates research funding to certain diseases, as well as a general fund. To date, researchers seeking grants related to rheumatic disease have had to apply via the general fund. The ACR is working toward having a line item dedicated to arthritis research, given that arthritis is the second-leading cause of medical discharge from the military. This slow-moving effort has gained serious traction, and I am hopeful we may be successful in this Congress.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)

Related Articles

    ACR Advocacy: 2021 Midyear Update

    June 13, 2021

    Beginning in the late 1800s, Eliza Ruhamah Scidmore, U.S. diplomat and writer, spent 24 years advocating for sakura, or Japanese cherry trees, to be planted in Washington, D.C. After unsuccessfully petitioning every U.S. Army Superintendent of Public Buildings and Grounds for over two decades, she wrote a letter to First Lady Helen Herron Taft about…

    The ACR’s 2020 Advocacy Year in Review

    February 16, 2021

    To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going.  As we look to 2021, we take lessons from our experiences in 2020. Washington,…

    ACR Advocacy: 2020 Year in Review

    January 11, 2021

    As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

    The Power of Advocacy

    January 10, 2022

    In 1916, a handful of conservation advocates successfully lobbied Congress to create the National Park Service, which now protects more than 85 million acres of U.S. land. Dedicated rheumatology advocacy has lasting effects, too, as evidenced by several policy wins in 2021 and efforts underway for 2022.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences